Ironwood Pharmaceuticals, Inc.IRWDNASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank79
3Y CAGR-13.4%
5Y CAGR+2.5%
Year-over-Year Change
EBITDA as a percentage of revenue
3Y CAGR
-13.4%/yr
Annual compound
5Y CAGR
+2.5%/yr
Recent deceleration
Percentile
P79
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | 41.30% | +48.5% |
| 2024 | 27.81% | -37.6% |
| 2023 | 44.59% | -30.0% |
| 2022 | 63.67% | +12.7% |
| 2021 | 56.49% | +55.1% |
| 2020 | 36.43% | +21.4% |
| 2019 | 30.01% | +172.0% |
| 2018 | -41.67% | -275.3% |
| 2017 | -11.10% | +2.8% |
| 2016 | -11.42% | - |